Back to Gene
LARS2 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

LARS2 gene

The LARS2 gene provides instructions for a mitochondrial enzyme essential for protein synthesis, with mutations linked to Perrault syndrome.

Overview

The LARS2 gene provides instructions for making an enzyme called mitochondrial leucyl-tRNA synthetase. This enzyme is vital for protein synthesis within mitochondria, the energy-producing centers of the cell.

During protein synthesis, transfer RNA (tRNA) molecules carry specific amino acids to the site where proteins are assembled. Aminoacyl-tRNA synthetases, such as mitochondrial leucyl-tRNA synthetase, are responsible for attaching the correct amino acid to its corresponding tRNA. Specifically, this enzyme attaches the amino acid leucine to the correct tRNA, ensuring that leucine is placed accurately within mitochondrial proteins.

Health Conditions Related to Genetic Changes

Perrault syndrome

Mutations in the LARS2 gene have been identified in individuals with Perrault syndrome. This condition is characterized by:

  • Hearing loss in both males and females
  • Abnormalities of the ovaries in females

The mutations reduce or eliminate the activity of the mitochondrial leucyl-tRNA synthetase enzyme. This shortage disrupts the assembly of new proteins within the mitochondria, which researchers speculate impairs mitochondrial energy production. While the link between these mutations and the specific symptoms of hearing loss and ovarian abnormalities is established, the exact biological mechanism remains under investigation.

Genomic Location

The LARS2 gene is found on chromosome 3.

Frequently Asked Questions

Patients may present with sensorineural hearing loss that begins in childhood or adolescence, and in females, ovarian dysfunction such as primary amenorrhea or premature ovarian insufficiency. If both features coexist, especially with a family history of similar findings, LARS2 should be considered.
Hearing aids or cochlear implants can improve auditory input. Regular audiologic monitoring is essential to adjust amplification as hearing thresholds change. Early intervention with speech therapy can also support language development.
Currently, there is no proven preventive treatment. However, early fertility counseling, hormone replacement therapy, and consideration of assisted reproductive technologies (e.g., egg freezing) can help preserve fertility. Genetic counseling is recommended for family planning.
Diagnosis starts with a clinical evaluation and audiologic testing. Genetic testing—often through a mitochondrial disease panel or whole-exome sequencing—identifies pathogenic variants in LARS2. Functional assays measuring mitochondrial protein synthesis or enzyme activity can support the diagnosis.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA